Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, in the context of the Conditional Marketing Authorisation awarded by the Medicines and Healthcare products Regulatory Agencyon 17 March 2022, what plans he has to (a) procure Evusheld and (b) roll out the treatment to severely immunocompromised patients.
We are unable to provide the information requested as this is commercially sensitive. Any public announcement would be made after an agreement is reached with companies.